Surgical Hemostats Market - Top Companies and Manufacturers

  • Report ID: 5638
  • Published Date: Apr 25, 2024
  • Report Format: PDF, PPT

Companies Dominating the Surgical Hemostats Landscape

top-features-companies
    • Ethicon, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Baxter International Inc.
    • Medtronic plc
    • B. Braun Melsungen AG
    • Pfizer Inc.
    • CryoLife, Inc.
    • C.R. Bard, Inc.
    • Integra LifeSciences Corporation
    • Z-Medica, LLC
    • Cardinal Health, Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • Baxter International Inc. a leading global MedTech company, announced the acquisition of Hillrom to expand its portfolio in the areas of acute treatments, surgical and critical care, and linked care, and to solidify the company's position as a top global MedTech provider.
  • Ethicon, Inc. obtained approval for ETHIZIA an adjunctive hemostat solution with a unique design that surgeons can rely on to function as well on both sides and is made for maximum versatility and gives them the confidence they need in every surgical scenario.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5638
  • Published Date: Apr 25, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of surgical hemostats was over USD 10 billion.

The market size for surgical hemostats is projected to cross USD 45 billion by the end of 2036 expanding at a CAGR of 12% through 2036.

The major players in the market are Baxter International Inc., Medtronic plc, B. Braun Melsungen AG, Pfizer Inc., CryoLife, Inc., C.R. Bard, Inc., Integra LifeSciences Corporation, Z-Medica, LLC, Cardinal Health, Inc., and others.

In terms of end-user, the hospitals segment is anticipated to account for the largest market share of 50% during 2024-2036.

The North American surgical hemostats sector is poised to hold the highest share of 35% by 2036.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying